ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
Dow Jones
38,852.86
-0.55%
US Dollar vs MXN
16.75375
-0.25%
Brent Oil
84.535
0.25%
Bitcoin
67,953.04
-0.49%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Forward Pharma AS (FWP)

  7. Forward Pharma AS (FWP) Noticias

FWP

Forward Pharma AS (FWP)

Forward Pharma AS
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FWP
FechaHoraFuenteTítuloSímboloCompañía
14/02/202315:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FWPForward Pharma AS
24/01/202305:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FWPForward Pharma AS
13/01/202315:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
06/01/202308:16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FWPForward Pharma AS
19/12/202205:00GlobeNewswire Inc.Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital MarketNASDAQ:FWPForward Pharma AS
06/12/202213:00GlobeNewswire Inc.Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for ReviewNASDAQ:FWPForward Pharma AS
08/04/202216:25GlobeNewswire Inc.Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021NASDAQ:FWPForward Pharma AS
13/12/202116:04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:FWPForward Pharma AS
13/12/202116:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FWPForward Pharma AS
06/09/202109:21GlobeNewswire Inc.Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal HearingNASDAQ:FWPForward Pharma AS
14/04/202115:40GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020NASDAQ:FWPForward Pharma AS
14/04/202115:20Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:FWPForward Pharma AS
12/01/202115:30GlobeNewswire Inc.Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 RestrictionsNASDAQ:FWPForward Pharma AS
11/09/202015:31Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:FWPForward Pharma AS
12/05/202016:00GlobeNewswire Inc.Forward Pharma Announces New Date for the EP2801355 Appeal Hearing due to COVID-19NASDAQ:FWPForward Pharma AS
24/04/202015:50GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2019NASDAQ:FWPForward Pharma AS
14/02/202015:27Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FWPForward Pharma AS
26/11/201915:05GlobeNewswire Inc.Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary SharesNASDAQ:FWPForward Pharma AS
05/09/201907:30GlobeNewswire Inc.Forward Pharma to Participate in the Fall Investor Summit in New YorkNASDAQ:FWPForward Pharma AS
26/06/201915:30GlobeNewswire Inc.Forward Pharma A/S Announces Intention to Transfer its U.S. Public Listing to the Nasdaq Capital Market Stock ExchangeNASDAQ:FWPForward Pharma AS
04/04/201915:30GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2018NASDAQ:FWPForward Pharma AS
27/03/201907:30GlobeNewswire Inc.Forward Pharma to Participate in the DKBIO2019 Life Science Investor ConferenceNASDAQ:FWPForward Pharma AS
24/10/201809:42GlobeNewswire Inc.Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent InterferenceNASDAQ:FWPForward Pharma AS
28/09/201806:30GlobeNewswire Inc.Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare ConferenceNASDAQ:FWPForward Pharma AS
19/09/201815:20GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the First Six Months of 2018NASDAQ:FWPForward Pharma AS
23/08/201807:00GlobeNewswire Inc.Forward Pharma to Participate in the LSX Nordic CongressNASDAQ:FWPForward Pharma AS
07/05/201815:30GlobeNewswire Inc.Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 PatentNASDAQ:FWPForward Pharma AS
02/05/201808:06GlobeNewswire Inc.Forward Pharma Reports Full-Year 2017 Financial and Operational ResultsNASDAQ:FWPForward Pharma AS
07/02/201806:30GlobeNewswire Inc.Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare ConferenceNASDAQ:FWPForward Pharma AS
29/01/201809:44GlobeNewswire Inc.Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 PatentNASDAQ:FWPForward Pharma AS
 Showing the most relevant articles for your search:NASDAQ:FWP

Su Consulta Reciente

COIN
XSPBTC
COIN
404GBP
UNSW
FORTHETH
Ampleforth Governance
LSE
NETW
Network
COIN
LKEBTC
NASDAQ
AXGT
Axovant Gene Therapies
LSE
51KA
Arkle 2060 A
LSE
19UT
Euro.bk. 43
TSX
ALC.DB.A
Algoma Central
BMF
DIIF31F35
DIIF31F35 - 01/2031
ASX
CAZN
USOTC
OTCSS
Otis Collection (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados